Sevoflurane is an ether inhalation anesthetic agent used to induce and maintain general anesthesia. It is a volatile, non-flammable compound with a low solubility profile and blood/gas partition coefficient. Sevoflurane was patented in 1972, was approved for clinical use in Japan in 1990, and approved by the FDA in 1996. Sevoflurane is three times more poten...
Sevoflurane is used for the induction and maintenance of general anesthesia in adult and pediatric patients for inpatient and outpatient surgery.
Mansoura University, Mansoura, DK, Egypt
Faculty of Medicine, University Hospitals, Shibīn Al Kawm, Menoufia, Egypt
Peking University First Hospital, Beijing, China
Kaohsiung Medical University Chung-Ho Memorial Hospital, Kaohsiung, Taiwan
Yonsei University Health System, Severance Hospital, Seoul, Korea, Republic of
Theodor Bilharz Research Institute, Cairo, Egypt
Endeavor Clinical Trials, San Antonio, Texas, United States
Ain Shams University, Cairo, Egypt
Anesthesiology Department of Affiliated Eye and ENT Hospital, Fudan University, Shanghai, Shanghai, China
Shanghai First Maternity and Infant Hospital, Tongji University School of Medicine, Shanghai, Shanghai, China
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.